NP-G2-044 (Prilukae), a novel oral fascin inhibitor, has earned orphan drug designation (ODD) from the FDA for the treatment ...

Novita Pharmaceuticals, Inc. ("Novita"), a privately held, clinical-stage pharmaceutical company dedicated to developing novel cancer drugs through its proprietary fascin inhibitor technology, today ...

Electronic data capture (EDC) extract from the ongoing ACR-368 registrational-intent Phase 2b monotherapy trial in OncoSignature-positive (BM+) subjects with endometrial cancer (EC) showed 39% overall ...

Electronic data capture (EDC) extract from the ongoing ACR-368 registrational-intent Phase 2b monotherapy trial in OncoSignature-positive (BM+) ...

Esports Insider asked prominent stakeholders, such as LEC, G2, Team Vitality, BLAST, Razer, and more, to predict what will ...

The Lebanese military says it has ended the first phase of its plan to deploy across southern Lebanon and disarm non-state groups, including Hezbollah ...

Novel small molecule inhibitors show promising efficacy in endometrial cancer, with ongoing trials expanding treatment ...

With no announcement posts or dramatic captions, the actor has subtly hinted at her 2026 slate through a simple update on her ...

T1 Energy Inc. announced it has finalized its first sale of Section 45X production tax credits to an investment-grade buyer on December 30, 2025. The transaction is valued at $160 million. The sale ...

Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment ...

Bitcoin’s role as a non-sovereign risk asset may benefit from renewed investor focus thanks to the criminal investigation ...